(Q28742896)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Why should primary care physicians know about breast cancer genetics?

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Linkage of early-onset familial breast cancer to chromosome 17q21

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Identification of the breast cancer susceptibility gene BRCA2

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

When research seems like clinical care: a qualitative study of the communication of individual cancer genetic research results

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Genetic health care services, present and near future in Japan.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Quality and safety of genetic testing in Australia and New Zealand: a review of the current regulatory framework

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Public health at center stage: new roles, old props.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

The licensing of DNA patents by US academic institutions: an empirical survey

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Controversies and ethical issues in cancer-genetics clinics

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Underwhelmed: hyperbole, regulatory policy, and the genetic revolution

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Specific keynote: hereditary ovarian cancer: what we know

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Effects of patents and licenses on the provision of clinical genetic testing services

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Patents and public health. European institutions are challenging Myriad Genetics's patent monopoly on the brca1 gene

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

BRCA1/2 genetic testing in the community setting

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Limitations of direct-to-consumer advertising for clinical genetic testing

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Sub-Saharan Africa thirty years hence.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Battling breast cancer. [Review of: Lerner, BH. The breast cancer wars: hope, fear, and the pursuit of a cure in twentieth-century America. Oxford University Press, 2001].

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Diagnostic testing fails the test

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

BRCA1, BRCA2 and breast cancer: a concise clinical review

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Can patents deter innovation? The anticommons in biomedical research

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Genetic analysis of breast cancer in the cancer and steroid hormone study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Discrimination as a consequence of genetic testing

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Myriad and the mass media: the covering of a gene patent controversy

3 June 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Health policy and the new genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

European groups oppose Myriad's latest patent on BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Concerns in a primary care population about genetic discrimination by insurers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Genetic discrimination: the clinician perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Testing for BRCA1 mutations: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Human Frontier repatriation boost.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

The European Biotech Directive: Past as Prologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Actor-Network Theory: a tool to support ethical analysis of commercial genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Psycho-social aspects of breast cancer susceptibility testing: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Genes and patent policy: rethinking intellectual property rights

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D72661

Intellectual property and biotechnology: the U.S. internal experience--Part I.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Gene patents and the death of dualism.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

The unexamined assumptions of intellectual property: adopting an evaluative approach to patenting biotechnological innovation.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

History of a gene patent: tracing the development and application of commercial BRCA testing

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

Patenting DNA and amino acid sequences--an Australian perspective.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037261

NCI-Myriad agreement offers BRCA testing at reduced cost

27 November 2018

1 reference

12 December 2020

Promoting safe and effective genetic testing in the United States. Final report of the Task Force on Genetic Testing

1 reference

12 December 2020

French refuse to implement biotech patent directive

1 reference

12 December 2020

Germany gives green light to gene patents

1 reference

12 December 2020

How human geneticists in US view commercialization of the Human Genome Project

1 reference

12 December 2020

Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population

1 reference

12 December 2020

Interest in BRCA1/2 testing in a primary care population

1 reference

12 December 2020

European-wide opposition against the breast cancer gene patents

1 reference

12 December 2020

Geneticists question fees for use of patented 'junk' DNA

1 reference

12 December 2020

Intellectual property. NIH roils academe with advice on licensing DNA patents

1 reference

12 December 2020

Architectures of genetic medicine: comparing genetic testing for breast cancer in the USA and the UK

1 reference

12 December 2020

Balancing innovation and access to healthcare through the patent system--an Australian perspective

1 reference

12 December 2020

The patent is political: the consequences of patenting the BRCA genes in Britain

1 reference

12 December 2020

Familial breast-ovarian cancer locus on chromosome 17q12-q23

1 reference

12 December 2020

Genes on the Web--direct-to-consumer marketing of genetic testing

1 reference

12 December 2020

Intellectual property and biotechnology: the U.S. internal experience--Part II

1 reference

12 December 2020

Contending visions in the evolution of genetic medicine: the case of cancer genetic services in Ontario, Canada

1 reference

12 December 2020

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

1 reference

12 December 2020

The battle over BRCA1 goes to court; BRCA2 may be next

1 reference

12 December 2020

Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions

1 reference

12 December 2020